Oncogenic retroviridae protein

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by KolbertBot (talk | contribs) at 07:42, 21 March 2018 (Bot: HTTP→HTTPS (v485)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Oncogenic retroviridae proteins are retroviral proteins that have the ability to transform cells. They can induce sarcomas, leukaemias, lymphomas, and mammary carcinomas. These include the gag-onc fusion protein, rex, tax, v-fms, ras, v-myc, v-src, v-akt, v-cbl, v-crk, v-maf, v-abl, v-erbA, v-erbB, v-fos, v-mos, v-myb, v-raf, v-rel, and v-sis. The "v" prefix indicates viral genes which once originated as similarly named genes of the host species, but have since been altered through independent evolution as retroviral components. Not all retroviral proteins are oncogenic.[1] The phrase was introduced as a MeSH term in 1990, under which over 6000 primary scientific publications are indexed.[2]

See also

Oncogenic

References

  1. ^ Definition: retroviridae proteins, oncogenic from Online Medical Dictionary
  2. ^ "MeSH browser entry".